Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR00149
|
|||||
| Drug Name |
Eluxadoline
|
|||||
| Synonyms |
MuDelta
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Indication | Diarrhea-predominant irritable bowel syndrome [ICD11: DD91.01] | Approved | [1] | |||
| Structure |
|
![]() |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C32H35N5O5
|
|||||
| Canonical SMILES |
CC1=CC(=CC(=C1CC(C(=O)N(CC2=CC(=C(C=C2)OC)C(=O)O)C(C)C3=NC=C(N3)C4=CC=CC=C4)N)C)C(=O)N
|
|||||
| InChI |
InChI=1S/C32H35N5O5/c1-18-12-23(29(34)38)13-19(2)24(18)15-26(33)31(39)37(17-21-10-11-28(42-4)25(14-21)32(40)41)20(3)30-35-16-27(36-30)22-8-6-5-7-9-22/h5-14,16,20,26H,15,17,33H2,1-4H3,(H2,34,38)(H,35,36)(H,40,41)/t20-,26-/m0/s1
|
|||||
| InChIKey |
QFNHIDANIVGXPE-FNZWTVRRSA-N
|
|||||
| CAS Number |
CAS 864821-90-9
|
|||||
| Pharmaceutical Properties | Molecular Weight | 569.6 | Topological Polar Surface Area | 165 | ||
| Heavy Atom Count | 42 | Rotatable Bond Count | 11 | |||
| Hydrogen Bond Donor Count | 4 | Hydrogen Bond Acceptor Count | 7 | |||
| XLogP |
0.9
|
|||||
| PubChem CID | ||||||
| PubChem SID | ||||||
| ChEBI ID |
ChEBI:85980
|
|||||
| TTD Drug ID | ||||||
| DT(s) Transporting This Drug | OATP1B1 | Transporter Info | Organic anion transporting polypeptide 1B1 | Substrate | [2] | |
| References | ||||||
| 1 | Eluxadoline was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019) | |||||
| 2 | Effect of uptake transporters OAT3 and OATP1B1 and efflux transporter MRP2 on the pharmacokinetics of eluxadoline. J Clin Pharmacol. 2015 May;55(5):534-42. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.
